Skip to main content
Top
Published in: Current Gastroenterology Reports 1/2016

01-01-2016 | Esophagus (J Clarke, Section Editor)

Ineffective Esophageal Motility (IEM): the Old-New Frontier in Esophagology

Authors: Ala’ A. Abdel Jalil, Donald O. Castell

Published in: Current Gastroenterology Reports | Issue 1/2016

Login to get access

Abstract

Ineffective esophageal motility (IEM) is characterized by distal esophageal contraction amplitude of <30 mmHg on conventional manometry (Blonski et al. Am J Gastroenterol. 103(3):699–704, 2008), or a distal contractile integral (DCI) < 450 mmHg*s*cm on high-resolution manometry (HRM) (Kahrilas et al. Neurogastroenterol Motil. 27(2):160–74, 2015) in≥50 % of test swallows. IEM is the most common abnormality on esophageal manometry, with an estimated prevalence of 20-30 % (Tutuian and Castell Am J Gastroenterol. 99(6):1011–9, 2004; Conchillo et al. Am J Gastroenterol. 100(12):2624–32, 2005). Non-obstructive dysphagia has been considered to be frequently associated with severe esophageal peristaltic dysfunction. Defective bolus transit (DBT) on multichannel intraluminal impedance testing was found in more than half of IEM patients who presented with dysphagia (Tutuian and Castell Am J Gastroenterol. 99(6):1011–9, 2004), highlighting the functional defect of this manometric finding. Treatment of IEM has been challenging because of lack of promotility agents that have a definite effect on esophageal function.
Literature
1.
go back to reference Pandolfino JE. Uncovering hidden information in achalasia using esophageal pressure topography. Gastroenterology. 2013;144(4):681–4.CrossRefPubMed Pandolfino JE. Uncovering hidden information in achalasia using esophageal pressure topography. Gastroenterology. 2013;144(4):681–4.CrossRefPubMed
2.
go back to reference Richter JE, Wu WC, Johns DN, Blackwell JN, Nelson 3rd JL, Castell JA, et al. Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of “abnormal” contractions. Dig Dis Sci. 1987;32(6):583–92.CrossRefPubMed Richter JE, Wu WC, Johns DN, Blackwell JN, Nelson 3rd JL, Castell JA, et al. Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of “abnormal” contractions. Dig Dis Sci. 1987;32(6):583–92.CrossRefPubMed
3.
go back to reference Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology. 1988;94(1):73–80.PubMed Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology. 1988;94(1):73–80.PubMed
4.•
go back to reference Leite LP, Johnston BT, Barrett J, Castell JA, Castell DO. Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Sci. 1997;42(9):1859–65. This paper has defined IEM as a peculiar and a more clear esophageal dysmotility entity.CrossRefPubMed Leite LP, Johnston BT, Barrett J, Castell JA, Castell DO. Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Sci. 1997;42(9):1859–65. This paper has defined IEM as a peculiar and a more clear esophageal dysmotility entity.CrossRefPubMed
6.
go back to reference Tutuian R, Castell DO. Clarification of the esophageal function defect in patients with manometric ineffective esophageal motility: studies using combined impedance-manometry. Clin Gastroenterol Hepatol. 2004;2:230–6.CrossRefPubMed Tutuian R, Castell DO. Clarification of the esophageal function defect in patients with manometric ineffective esophageal motility: studies using combined impedance-manometry. Clin Gastroenterol Hepatol. 2004;2:230–6.CrossRefPubMed
7.••
go back to reference Blonski W, Vela M, Safder A, Hila A, Castell DO. Revised criterion for diagnosis of ineffective esophageal motility is associated with more frequent dysphagia and greater bolus transit abnormalities. Am J Gastroenterol. 2008;103(3):699–704. This paper emphasized the clinical and functional aspects of IEM, especially with severe disease.CrossRefPubMed Blonski W, Vela M, Safder A, Hila A, Castell DO. Revised criterion for diagnosis of ineffective esophageal motility is associated with more frequent dysphagia and greater bolus transit abnormalities. Am J Gastroenterol. 2008;103(3):699–704. This paper emphasized the clinical and functional aspects of IEM, especially with severe disease.CrossRefPubMed
8.
go back to reference Pandolfino JE. High-resolution manometry: is it better for detecting esophageal disease? Gastroenterol Hepatol. 2010;6(10):632–4. Pandolfino JE. High-resolution manometry: is it better for detecting esophageal disease? Gastroenterol Hepatol. 2010;6(10):632–4.
9.••
go back to reference Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, et al. International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74. This paper re-introduced the term of IEM into Chicago Classification, underscoring the clinical relevance of the condition.CrossRefPubMed Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, et al. International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160–74. This paper re-introduced the term of IEM into Chicago Classification, underscoring the clinical relevance of the condition.CrossRefPubMed
10.
go back to reference Xiao Y, Kahrilas PJ, Kwasny MJ, Roman S, Lin Z, Nicodeme F, et al. High-resolution manometry correlates of ineffective esophageal motility. Am J Gastroenterol. 2012;107:1647–54.PubMedCentralCrossRefPubMed Xiao Y, Kahrilas PJ, Kwasny MJ, Roman S, Lin Z, Nicodeme F, et al. High-resolution manometry correlates of ineffective esophageal motility. Am J Gastroenterol. 2012;107:1647–54.PubMedCentralCrossRefPubMed
11.
go back to reference Ho SC, Chang CS, Wu CY, Chen GH. Ineffective esophageal motility is a primary motility disorder in gastroesophageal reflux disease. Dig Dis Sci. 2002;47(3):652–6.CrossRefPubMed Ho SC, Chang CS, Wu CY, Chen GH. Ineffective esophageal motility is a primary motility disorder in gastroesophageal reflux disease. Dig Dis Sci. 2002;47(3):652–6.CrossRefPubMed
12.
go back to reference Ahmed W, Vohra EA. Esophageal motility disorders in diabetics with and without neuropathy. J Pak Med Assoc. 2006;56(2):54–8.PubMed Ahmed W, Vohra EA. Esophageal motility disorders in diabetics with and without neuropathy. J Pak Med Assoc. 2006;56(2):54–8.PubMed
13.
go back to reference Yamada T. Motor disorders of the esophagus. In: Yamada T, editor. Handbook of gastroenterology. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 193–203. Yamada T. Motor disorders of the esophagus. In: Yamada T, editor. Handbook of gastroenterology. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 193–203.
14.
go back to reference Bu BG, Linghu EQ, Li HK, Wang XX, Guo RB, Peng LH. Influence of endoscopic submucosal dissection on esophageal motility. World J Gastroenterol. 2013;19(29):4781–5.PubMedCentralCrossRefPubMed Bu BG, Linghu EQ, Li HK, Wang XX, Guo RB, Peng LH. Influence of endoscopic submucosal dissection on esophageal motility. World J Gastroenterol. 2013;19(29):4781–5.PubMedCentralCrossRefPubMed
15.
go back to reference Dent J. A new technique for continuous sphincter pressure measurement. Gastroenterology. 1976;71:263–7.PubMed Dent J. A new technique for continuous sphincter pressure measurement. Gastroenterology. 1976;71:263–7.PubMed
16.
go back to reference Pandolfino JE, Kahrilas PJ. American Gastroenterological Association medical position statement: Clinical use of esophageal manometry. Gastroenterology. 2005;128:207–8.CrossRefPubMed Pandolfino JE, Kahrilas PJ. American Gastroenterological Association medical position statement: Clinical use of esophageal manometry. Gastroenterology. 2005;128:207–8.CrossRefPubMed
17.
18.
go back to reference Savarino E, Tutuian R. Combined multichannel intraluminal impedance and manometry testing. Dig Liver Dis. 2008;40:167–73.CrossRefPubMed Savarino E, Tutuian R. Combined multichannel intraluminal impedance and manometry testing. Dig Liver Dis. 2008;40:167–73.CrossRefPubMed
19.
go back to reference Jacob P, Kahrilas PJ, Vanagunas A. Peristaltic dysfunction associated with nonobstructive dysphagia in reflux disease. Dig Dis Sci. 1990;35(8):939–42.CrossRefPubMed Jacob P, Kahrilas PJ, Vanagunas A. Peristaltic dysfunction associated with nonobstructive dysphagia in reflux disease. Dig Dis Sci. 1990;35(8):939–42.CrossRefPubMed
20.
go back to reference Domingues GR, Winograd R, Lemme EM, Lammert F, Silny J, Matern S, et al. Characteristics of esophageal bolus transport in patients with mild oesophagitis. Eur J Gastroenterol Hepatol. 2005;17(3):323–32.CrossRefPubMed Domingues GR, Winograd R, Lemme EM, Lammert F, Silny J, Matern S, et al. Characteristics of esophageal bolus transport in patients with mild oesophagitis. Eur J Gastroenterol Hepatol. 2005;17(3):323–32.CrossRefPubMed
21.
go back to reference Savarino E, Gemignani L, Pohl D, Zentilin P, Dulbecco P, Assandri L, et al. Esophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-esophageal reflux disease. Aliment Pharmacol Ther. 2011;34:476–86.CrossRefPubMed Savarino E, Gemignani L, Pohl D, Zentilin P, Dulbecco P, Assandri L, et al. Esophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-esophageal reflux disease. Aliment Pharmacol Ther. 2011;34:476–86.CrossRefPubMed
22.
go back to reference Lee J, Anggiansah A, Anggiansah R, Young A, Wong T, Fox M. Effects of age on the gastroesophageal junction, esophageal motility, and reflux disease. Clin Gastroenterol Hepatol. 2007;5:1392–8.CrossRefPubMed Lee J, Anggiansah A, Anggiansah R, Young A, Wong T, Fox M. Effects of age on the gastroesophageal junction, esophageal motility, and reflux disease. Clin Gastroenterol Hepatol. 2007;5:1392–8.CrossRefPubMed
23.
go back to reference Wu JC, Cheung CM, Wong VW, Sung JJ. Distinct clinical characteristics between patients with non-erosive reflux disease and those with reflux esophagitis. Clin Gastroenterol Hepatol. 2007;5:690–5.CrossRefPubMed Wu JC, Cheung CM, Wong VW, Sung JJ. Distinct clinical characteristics between patients with non-erosive reflux disease and those with reflux esophagitis. Clin Gastroenterol Hepatol. 2007;5:690–5.CrossRefPubMed
24.
go back to reference Fouad YM, Katz PO, Hatlebakk JG, Castell DO. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. Am J Gastroenterol. 1999;94:1464–7.CrossRefPubMed Fouad YM, Katz PO, Hatlebakk JG, Castell DO. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. Am J Gastroenterol. 1999;94:1464–7.CrossRefPubMed
25.
go back to reference Rackoff A, Agrawal A, Hila A, Mainie I, Tutuian R, Castell DO. Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy. Dis Esophagus. 2005;18(6):370–3.CrossRefPubMed Rackoff A, Agrawal A, Hila A, Mainie I, Tutuian R, Castell DO. Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy. Dis Esophagus. 2005;18(6):370–3.CrossRefPubMed
26.
go back to reference Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicenter study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398–402.PubMedCentralCrossRefPubMed Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicenter study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398–402.PubMedCentralCrossRefPubMed
27.
go back to reference Han SH, Hong SJ. Transient lower esophageal sphincter relaxation and the related esophageal motor activities. Korean J Gastroenterol. 2012;59(3):205–10.CrossRefPubMed Han SH, Hong SJ. Transient lower esophageal sphincter relaxation and the related esophageal motor activities. Korean J Gastroenterol. 2012;59(3):205–10.CrossRefPubMed
28.
go back to reference Zhang Q, Lehmann A, Rigda R, Dent J, Holloway RH. Control of transient lower esophageal sphincter relaxations and reflux by the GABA (B) agonist baclofen in patients with gastro-esophageal reflux disease. Gut. 2002;50:19–24.PubMedCentralCrossRefPubMed Zhang Q, Lehmann A, Rigda R, Dent J, Holloway RH. Control of transient lower esophageal sphincter relaxations and reflux by the GABA (B) agonist baclofen in patients with gastro-esophageal reflux disease. Gut. 2002;50:19–24.PubMedCentralCrossRefPubMed
29.
go back to reference Lidums I, Lehmann A, Checklin H, Dent J, Holloway RH. Control of transient lower esophageal sphincter relaxations and reflux by the GABA (B) agonist baclofen in normal subjects. Gastroenterology. 2000;118:7–13.CrossRefPubMed Lidums I, Lehmann A, Checklin H, Dent J, Holloway RH. Control of transient lower esophageal sphincter relaxations and reflux by the GABA (B) agonist baclofen in normal subjects. Gastroenterology. 2000;118:7–13.CrossRefPubMed
30.
go back to reference Blonski W, Vela MF, Freeman J, Sharma N, Castell DO. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. J Clin Gastroenterol. 2009;43(3):253–60.CrossRefPubMed Blonski W, Vela MF, Freeman J, Sharma N, Castell DO. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. J Clin Gastroenterol. 2009;43(3):253–60.CrossRefPubMed
31.••
go back to reference Agrawal A, Hila A, Tutuian R, Mainie I, Castell DO. Bethanechol improves smooth muscle function in patients with severe ineffective esophageal motility. J Clin Gastroenterol. 2007;41(4):366–70. This paper provides an evidence of utility of Bethanechol, as a cholinergic agent, in patients with IEM.CrossRefPubMed Agrawal A, Hila A, Tutuian R, Mainie I, Castell DO. Bethanechol improves smooth muscle function in patients with severe ineffective esophageal motility. J Clin Gastroenterol. 2007;41(4):366–70. This paper provides an evidence of utility of Bethanechol, as a cholinergic agent, in patients with IEM.CrossRefPubMed
32.
go back to reference Song CW, UM SH, Kim CD, Ryu HS, Hyun JH, Choe JG. Double-blind placebo-controlled study of cisapride in patients with nonspecific esophageal motility disorder accompanied by delayed esophageal transit. Scand J Gastroenterol. 1997;32(6):541–6.CrossRefPubMed Song CW, UM SH, Kim CD, Ryu HS, Hyun JH, Choe JG. Double-blind placebo-controlled study of cisapride in patients with nonspecific esophageal motility disorder accompanied by delayed esophageal transit. Scand J Gastroenterol. 1997;32(6):541–6.CrossRefPubMed
33.
go back to reference Michalets EL, Williams CR. Drug interactions with cisapride: clinical implications. Clin Pharmacokinet. 2000;39(1):49–75.CrossRefPubMed Michalets EL, Williams CR. Drug interactions with cisapride: clinical implications. Clin Pharmacokinet. 2000;39(1):49–75.CrossRefPubMed
34.
go back to reference Chen CL, Yi CH, Liu TT, Orr WC. Effects of mosapride on secondary peristalsis in patients with ineffective esophageal motility. Scand J Gastroenterol. 2013;48(12):1363–70.CrossRefPubMed Chen CL, Yi CH, Liu TT, Orr WC. Effects of mosapride on secondary peristalsis in patients with ineffective esophageal motility. Scand J Gastroenterol. 2013;48(12):1363–70.CrossRefPubMed
35.
go back to reference Johnsson F, Holloway RH, Ireland AC, Jamieson GG, Dent J. Effect of fundoplication on transient lower oesophageal sphincter relaxation and gas reflux. Br J Surg. 1997;84:686–9.CrossRefPubMed Johnsson F, Holloway RH, Ireland AC, Jamieson GG, Dent J. Effect of fundoplication on transient lower oesophageal sphincter relaxation and gas reflux. Br J Surg. 1997;84:686–9.CrossRefPubMed
36.
go back to reference Bredenoord AJ, Draaisma WA, Weusten BL, Gooszen HG, Smout AJ. Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery. Gut. 2008;57:161–6.CrossRefPubMed Bredenoord AJ, Draaisma WA, Weusten BL, Gooszen HG, Smout AJ. Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery. Gut. 2008;57:161–6.CrossRefPubMed
37.•
go back to reference Sheu EG, Nau P, Nath B, Kuo B, Rattner DW. A comparative trial of laparoscopic magnetic sphincter augmentation and Nissen fundoplication. Surg Endosc. 2015;29(3):505–9. This paper provides comparative results for treatment of GERD (and IEM if present secondarily) with standard use of fundoplication vs. a newer LINX device.CrossRefPubMed Sheu EG, Nau P, Nath B, Kuo B, Rattner DW. A comparative trial of laparoscopic magnetic sphincter augmentation and Nissen fundoplication. Surg Endosc. 2015;29(3):505–9. This paper provides comparative results for treatment of GERD (and IEM if present secondarily) with standard use of fundoplication vs. a newer LINX device.CrossRefPubMed
38.
go back to reference Bonavina L, Saino G, Lipham JC, Demeester TR. LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux. Ther Adv Gastroenterol. 2013;6(4):261–8.CrossRef Bonavina L, Saino G, Lipham JC, Demeester TR. LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux. Ther Adv Gastroenterol. 2013;6(4):261–8.CrossRef
39.
go back to reference Reynolds JL, Zehetner J, Bildzukewicz N, Katkhouda N, Dandekar G, Lipham JC. Magnetic sphincter augmentation with the LINX device for gastroesophageal reflux disease after U.S. Food and Drug Administration approval. Am Surg. 2014;80(10):1034–8.PubMed Reynolds JL, Zehetner J, Bildzukewicz N, Katkhouda N, Dandekar G, Lipham JC. Magnetic sphincter augmentation with the LINX device for gastroesophageal reflux disease after U.S. Food and Drug Administration approval. Am Surg. 2014;80(10):1034–8.PubMed
40.•
go back to reference Bell RC, Barnes WE, Carter BJ, Sewell RW, Mavrelis PG, Ihde GM, et al. Transoral incisionless fundoplication: 2-year results from the prospective multicenter U.S. study. Am Surg. 2014;80(11):1093–105. This paper elucidates on efficacy of an innovative endoscopic treatment of GERD, a major causative vs. associated condition with IEM.PubMed Bell RC, Barnes WE, Carter BJ, Sewell RW, Mavrelis PG, Ihde GM, et al. Transoral incisionless fundoplication: 2-year results from the prospective multicenter U.S. study. Am Surg. 2014;80(11):1093–105. This paper elucidates on efficacy of an innovative endoscopic treatment of GERD, a major causative vs. associated condition with IEM.PubMed
41.
go back to reference Hunter JG, Kahrilas PJ, Bell RC, Wilson EB, Trad KS, Dolan JP, et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148(2):324–33. e5.CrossRefPubMed Hunter JG, Kahrilas PJ, Bell RC, Wilson EB, Trad KS, Dolan JP, et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148(2):324–33. e5.CrossRefPubMed
42.•
go back to reference Tutuian R, Castell DO. Combined multichannel intraluminal impedance and manometry clarifies esophageal function abnormalities: study in 350 patients. Am J Gastroenterol. 2004;99(6):1011–9. This paper describes the functional defect in IEM patients on impedance measurmet.CrossRefPubMed Tutuian R, Castell DO. Combined multichannel intraluminal impedance and manometry clarifies esophageal function abnormalities: study in 350 patients. Am J Gastroenterol. 2004;99(6):1011–9. This paper describes the functional defect in IEM patients on impedance measurmet.CrossRefPubMed
43.
go back to reference Conchillo JM, Nguyen NQ, Samsom M, Holloway RH, Smout AJ. Multichannel intraluminal impedance monitoring in the evaluation of patients with non-obstructive Dysphagia. Am J Gastroenterol. 2005;100(12):2624–32.CrossRefPubMed Conchillo JM, Nguyen NQ, Samsom M, Holloway RH, Smout AJ. Multichannel intraluminal impedance monitoring in the evaluation of patients with non-obstructive Dysphagia. Am J Gastroenterol. 2005;100(12):2624–32.CrossRefPubMed
Metadata
Title
Ineffective Esophageal Motility (IEM): the Old-New Frontier in Esophagology
Authors
Ala’ A. Abdel Jalil
Donald O. Castell
Publication date
01-01-2016
Publisher
Springer US
Published in
Current Gastroenterology Reports / Issue 1/2016
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-015-0472-y

Other articles of this Issue 1/2016

Current Gastroenterology Reports 1/2016 Go to the issue

Large Intestine (B Cash, Section Editor)

Update on Difficult Polypectomy Techniques

Pediatric Gastroenterology (SR Orenstein, Section Editor)

Pediatric Rectal Exam: Why, When, and How

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.